We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.04B
AUM Growth
+$1.26B
Cap. Flow
+$1.24B
Cap. Flow %
24.63%
Top 10 Hldgs %
29.33%
Holding
6,215
New
531
Increased
2,728
Reduced
2,144
Closed
536

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$165M
2
MSFT icon
Microsoft
MSFT
+$143M
3
NVDA icon
NVIDIA
NVDA
+$128M
4
AMZN icon
Amazon
AMZN
+$86.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.4M

Sector Composition

Rank Sector Weight
1 Technology 28.99%
2 Financials 11.06%
3 Consumer Discretionary 10.07%
4 Communication Services 8.96%
5 Healthcare 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYTA icon
4376
SGI Dynamic Tactical ETF
DYTA
$107M
$4.94K ﹤0.01%
178
+1
+0.6% +$31
MBOT icon
4377
Microbot Medical
MBOT
$113M
$4.93K ﹤0.01%
4,406
-569
-11% -$557
PRHI
4378
Presurance Holdings
PRHI
$17M
$4.91K ﹤0.01%
599
+147
+33% +$1.17K
APEI icon
4379
American Public Education
APEI
$837M
$4.9K ﹤0.01%
227
-4,329
-95% -$77.8K
AGM.A icon
4380
Federal Agricultural Mortgage Class A
AGM.A
$1.77B
$4.88K ﹤0.01%
33
-7
-18% -$1.06K
RFIL icon
4381
RF Industries
RFIL
$139M
$4.88K ﹤0.01%
1,249
+137
+12% +$554
GSM icon
4382
FerroAtlántica
GSM
$854M
$4.88K ﹤0.01%
1,285
-22,684
-95% -$97.3K
CBIO
4383
Crescent Biopharma
CBIO
$620M
$4.87K ﹤0.01%
+196
New +$5.34K
IRD
4384
Opus Genetics
IRD
$323M
$4.87K ﹤0.01%
4,088
+711
+21% +$816
APRE icon
4385
Aprea Therapeutics
APRE
$8.17M
$4.86K ﹤0.01%
1,478
+163
+12% +$545
FRD icon
4386
Friedman Industries
FRD
$309M
$4.86K ﹤0.01%
318
XWEL icon
4387
XWELL
XWEL
$8.36M
$4.86K ﹤0.01%
3,219
+852
+36% +$1.39K
GFL icon
4388
GFL Environmental
GFL
$14.9B
$4.86K ﹤0.01%
109
-2,750
-96% -$120K
SBGI icon
4389
Sinclair Inc
SBGI
$989M
$4.84K ﹤0.01%
300
-2,755
-90% -$46.4K
CMCO icon
4390
Columbus McKinnon
CMCO
$564M
$4.84K ﹤0.01%
130
-7,868
-98% -$286K
GEVO icon
4391
Gevo
GEVO
$403M
$4.84K ﹤0.01%
2,316
-27,447
-92% -$52K
BLDP
4392
Ballard Power Systems
BLDP
$784M
$4.82K ﹤0.01%
2,901
-3,774
-57% -$5.88K
PXLW icon
4393
Pixelworks
PXLW
$38.3M
$4.82K ﹤0.01%
550
-193
-26% -$1.75K
NTES icon
4394
NetEase
NTES
$81.9B
$4.82K ﹤0.01%
54
-3,329
-98% -$292K
SXTP icon
4395
60 Degrees Pharmaceuticals
SXTP
$3M
$4.81K ﹤0.01%
187
+113
+153% +$2.49K
IHT
4396
InnSuites Hospitality Trust
IHT
$14.7M
$4.81K ﹤0.01%
2,226
-906
-29% -$1.85K
SUIG
4397
Sui Group Holdings
SUIG
$66.9M
$4.8K ﹤0.01%
2,461
-287
-10% -$575
SMSI icon
4398
Smith Micro Software
SMSI
$16.6M
$4.78K ﹤0.01%
730
-65
-8% -$301
INAB icon
4399
IN8bio
INAB
$10.3M
$4.77K ﹤0.01%
619
+179
+41% +$1.57K
OGI
4400
Organigram Holdings
OGI
$173M
$4.77K ﹤0.01%
2,982
+150
+5% +$244

Similar funds

Tower Research Capital (TRC)'s Q4 2024 Portfolio in Review

As of Q4 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.04B, up 33% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.24B of net new capital in Q4 2024, opening 531 new positions and adding to 2,728 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $296M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2024 buy was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2024, an estimated $165M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $296M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q4 2024, selling an estimated $30.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.04B portfolio in Q4 2024.
  • Tower Research Capital (TRC) opened 531 new positions and closed 536 in Q4 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 33% quarter-over-quarter to $5.04B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.